Strongbridge Biopharma Stock Forecast, Price & News

Strongbridge Biopharma (NASDAQ:SBBP) Frequently Asked Questions

Is Strongbridge Biopharma a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Strongbridge Biopharma in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Strongbridge Biopharma stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBBP, but not buy additional shares or sell existing shares.
View analyst ratings for Strongbridge Biopharma or view top-rated stocks.

How were Strongbridge Biopharma's earnings last quarter?

Strongbridge Biopharma plc (NASDAQ:SBBP) announced its quarterly earnings results on Thursday, August, 5th. The biotechnology company reported ($0.21) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.09. The biotechnology company had revenue of $10.04 million for the quarter, compared to analyst estimates of $8.83 million. Strongbridge Biopharma had a negative net margin of 115.67% and a negative trailing twelve-month return on equity of 66.82%.
View Strongbridge Biopharma's earnings history.

What price target have analysts set for SBBP?

3 Wall Street analysts have issued 1-year price targets for Strongbridge Biopharma's shares. Their forecasts range from $3.25 to $10.00. On average, they expect Strongbridge Biopharma's stock price to reach $6.63 in the next twelve months. This suggests a possible upside of 231.3% from the stock's current price.
View analysts' price targets for Strongbridge Biopharma or view top-rated stocks among Wall Street analysts.

Who are Strongbridge Biopharma's key executives?

Strongbridge Biopharma's management team includes the following people:

• John H. Johnson, Chief Executive Officer & Director
• Richard S. Kollender, President & Chief Financial Officer
• Fredric Cohen, Chief Medical Officer
• Brian Conner, Chief Compliance Officer
• Peter J. Valentinsson, Senior Vice President-Global Technical Operations

Who are some of Strongbridge Biopharma's key competitors?

Some companies that are related to Strongbridge Biopharma include LianBio (LIAN), Albireo Pharma (ALBO), Fulcrum Therapeutics (FULC), Inventiva (IVA), BioXcel Therapeutics (BTAI), Relmada Therapeutics (RLMD), Lexicon Pharmaceuticals (LXRX), POINT Biopharma Global (PNT), SIGA Technologies (SIGA), Intercept Pharmaceuticals (ICPT), Chimerix (CMRX), Deciphera Pharmaceuticals (DCPH), Y-mAbs Therapeutics (YMAB), VBI Vaccines (VBIV) and Tyra Biosciences (TYRA).
View all of SBBP's competitors.

What other stocks do shareholders of Strongbridge Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Strongbridge Biopharma investors own include SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Energy Transfer (ET), Selecta Biosciences (SELB), Rigel Pharmaceuticals (RIGL), Agile Therapeutics (AGRX), Dicerna Pharmaceuticals (DRNA), Dynavax Technologies (DVAX) and Matinas BioPharma (MTNB).

What is Strongbridge Biopharma's stock symbol?

Strongbridge Biopharma trades on the NASDAQ under the ticker symbol "SBBP."

What is Strongbridge Biopharma's stock price today?

One share of SBBP stock can currently be purchased for approximately $2.00.

How much money does Strongbridge Biopharma make?

Strongbridge Biopharma has a market capitalization of $135.66 million and generates $30.73 million in revenue each year. The biotechnology company earns $-45.08 million in net income (profit) each year or ($0.78) on an earnings per share basis.

How many employees does Strongbridge Biopharma have?

Strongbridge Biopharma employs 72 workers across the globe.

What is Strongbridge Biopharma's official website?

The official website for Strongbridge Biopharma is www.strongbridgebio.com.

Where are Strongbridge Biopharma's headquarters?

Strongbridge Biopharma is headquartered at 900 NORTHBROOK DRIVE SUITE 200, TREVOSE PA, 19053.

How can I contact Strongbridge Biopharma?

Strongbridge Biopharma's mailing address is 900 NORTHBROOK DRIVE SUITE 200, TREVOSE PA, 19053. The biotechnology company can be reached via phone at (610) 254-9200 or via email at [email protected].